RxDoctor Payments Data

John Holds, MD

Plastic and Reconstructive Surgery · Saint Louis, MONPI 1134117732

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $32,220 of the $39,800 with a category attached, or 81.0%. Amgen accounts for 92.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $13,367 and has fallen 93.5% since, to $874 in 2025. Among plastic and reconstructive surgery clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,800in general payments, 2019–2025

Across 197 payments — averaging $202.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$37K
  • AbbVie$1K
  • ANI Pharmaceuticals, Inc.$223
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$206
  • Galderma Laboratories, L.p.$193
  • Revance Therapeutics, Inc.$174
  • plus $702 from 12 others

What the payments were for

  • Speaking & faculty fees$32,22081%
  • Travel & lodging$2,6437%
  • Food & beverage$4,93712%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,800 in reported general payments places this provider in the 90th percentile of 61 plastic and reconstructive surgery providers in Missouri.

See all plastic and reconstructive surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$234,390
Medicare patients
241
Services billed
18,266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate28$2,764
ErythromycinErythromycin Base239$2,182
Prednisolone Acetate37$958
Cephalexin34$369
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha41$291
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen86$271
Fluticasone Propionate12$103
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$78
Ondansetron OdtOndansetron22$71
Lorazepam11$68
Tramadol Hcl17$38
Clonazepam12$35

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →